FDA Inspection 1079698 — Hisun Pharmaceutical Hangzhou Co., Ltd
The FDA completed an inspection of Hisun Pharmaceutical Hangzhou Co., Ltd on Jan 25, 2019 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Hangzhou (China)